All Stories

  1. Reporting guidelines for protocols of randomised controlled trials of implantable neurostimulation devices: the SPIRIT-iNeurostim extension
  2. Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension
  3. Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society’s recommendations for best clinical practice
  4. Comment on ‘A sham‐controlled, randomized trial of spinal cord stimulation for the treatment of pain in chronic pancreatitis’ by Gulisano et al.
  5. Does industry funding and study location impact findings from randomized controlled trials of spinal cord stimulation? A systematic review and meta-analysis
  6. Limitations of the Cochrane review of spinal cord stimulation for low back pain
  7. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
  8. Issues in patient cohort, surrogate outcome measures and conflicts of interest of JAMA Neurology's Dhruva et al. propensity‐matched retrospective evaluation of a single insurer administrative claims data of spinal cord stimulation compared w...
  9. Response to Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466–2475
  10. Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain
  11. Contact heat in Magnetoencephalography: A Systematic Review
  12. Issues in design, conduct, and conclusions of JAMA 's Hara et al.'s randomized clinical trial of spinal cord burst stimulation versus placebo stimulation on disability in patients with chronic radicular pain after lum...
  13. Health effects of liquid and gaseous fuels for household energy use: Systematic evidence mapping
  14. Ziconotide for the Management of Cancer Pain: A Budget Impact Analysis
  15. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy
  16. Association Between Levels of Functional Disability and Health-Related Quality of Life With Spinal Cord Stimulation for Chronic Pain
  17. Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis
  18. Patient Selection for Spinal Cord Stimulation in Treatment of Pain: Sequential Decision-Making Model — A Narrative Review
  19. Predicting patient-reported outcomes following lumbar spine surgery: development and external validation of multivariable prediction models
  20. Systematic review and meta-analysis of predictors of return to work after spinal surgery for chronic low back and leg pain
  21. Cross‐Country Differences in Pain Medication Before and After Spinal Cord Stimulation: A Pooled Analysis of Individual Patient Data From Two Prospective Studies in the United Kingdom and Belgium
  22. Systematic Review of the Effectiveness of Machine Learning Algorithms for Classifying Pain Intensity, Phenotype or Treatment Outcomes Using Electroencephalogram Data
  23. Are cleaner cooking solutions clean enough? A systematic review and meta-analysis of particulate and carbon monoxide concentrations and exposures
  24. A prospective long-term follow-up of dorsal root ganglion stimulation for the management of chronic intractable pain
  25. Exploration of the Supraspinal Hypotheses about Spinal Cord Stimulation and Dorsal Root Ganglion Stimulation: A Systematic Review
  26. Analgesic Efficacy of “Burst” and Tonic ( 500 Hz ) Spinal Cord Stimulation Patterns: A Randomized Placebo‐Controlled Crossover Study
  27. A systematic review of health state utility values for thyroid cancer
  28. Mindfulness‐based cognitive therapy for prevention and time to depressive relapse: systematic review and network meta‐analysis
  29. Reply to Sharma et al.
  30. The Unmet Need for Intrathecal Drug Delivery Pumps for the Treatment of Cancer Pain in England: An Assessment of the Hospital Episode Statistics Database
  31. Health‐Related Quality of Life Associated With Pain Health States in Spinal Cord Stimulation for Chronic Neuropathic Pain
  32. Antibiotic therapy for pelvic inflammatory disease
  33. Advances in Neurostimulation for Chronic Pain Disorders
  34. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial
  35. A Systematic Review of Economic Evaluations Reporting the Cost-Effectiveness of Spinal Cord Stimulation
  36. Pilot service evaluation of a brief psychological therapy for self‐harm in an emergency department: Hospital Outpatient Psychotherapy Engagement Service
  37. The timing and quality of antenatal care received by women attending a primary care centre in Iquitos, Peru: A facility exit survey
  38. Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol
  39. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
  40. Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
  41. Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain
  42. Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation
  43. A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine
  44. Correction to: Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial
  45. Protocol for a systematic review and network meta-analysis of the management of new onset atrial fibrillation in critically unwell adult patients
  46. The effect of mindfulness practice on aggression and violence levels in adults: A systematic review
  47. Randomized Placebo‐/Sham‐Controlled Trials of Spinal Cord Stimulation: A Systematic Review and Methodological Appraisal
  48. Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  49. Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  50. Biologic Drugs as Analgesics for the Management of Low Back Pain and Sciatica
  51. Trial Versus No Trial of Spinal Cord Stimulation for Chronic Neuropathic Pain: Cost Analysis in United Kingdom National Health Service
  52. Are acceptance and mindfulness-based interventions ‘value for money’? Evidence from a systematic literature review
  53. Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial
  54. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials
  55. Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  56. COMMONLY UTILIZED PHYSIOTHERAPY TREATMENT APPROACHES IN THE MANAGEMENT OF SUB-ACUTE SCIATICA: A DELPHI STUDY
  57. EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
  58. Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis
  59. Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  60. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
  61. Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review
  62. Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations
  63. Antibiotic therapy for pelvic inflammatory disease
  64. Mindfulness-Based Interventions During Pregnancy: a Systematic Review and Meta-analysis
  65. A Spinal Cord Stimulation Service Review From a Single Centre Using a Single Manufacturer Over a 7.5 Year Follow-Up Period
  66. EDITORIAL (Thematic Selection: Spinal Neuropharmacological Agents for the Management of Pain)
  67. Biologic drugs as analgesics for the management of osteoarthritis
  68. The effects of opioids on the endocrine system: an overview
  69. Comparison of the Effects of Intermittent Boluses to Simple Continuous Infusion on Patients’ Global Perceived Effect in Intrathecal Therapy for Pain: A Randomized Double-Blind Crossover Study
  70. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging
  71. Intrathecal drug delivery systems for the management of chronic non-cancer pain: protocol for a systematic review of economic evaluations
  72. Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol
  73. An overview of treatment approaches for chronic pain management
  74. Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical Management
  75. Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation
  76. Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature
  77. Brain activity modifications following spinal cord stimulation for chronic neuropathic pain: A systematic review
  78. Electroencephalographic evoked pain response is suppressed by spinal cord stimulation in complex regional pain syndrome: a case report
  79. The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled Trial
  80. A review of antibiotic therapy for pelvic inflammatory disease
  81. Attrition with spinal cord stimulation
  82. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
  83. Intrathecal drug delivery for the management of pain and spasticity in adults: an executive summary of the British Pain Society’s recommendations for best clinical practice
  84. COMMONLY UTILIZED PHYSIOTHERAPY TREATMENT APPROACHES IN THE MANAGEMENT OF SUB-ACUTE SCIATICA: A PILOT STUDY USING THE DELPHI PROCESS
  85. Neuropathic pain in osteoarthritis: A review of pathophysiological mechanisms and implications for treatment
  86. The Pros and Cons of Long-Term Opioid Therapy
  87. Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model
  88. Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain
  89. Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy
  90. Antibiotic therapy for pelvic inflammatory disease (PID)
  91. Qualitative exploration of psychological factors associated with spinal cord stimulation outcome
  92. Intrathecal granuloma formation as result of opioid delivery: Systematic literature review of case reports and analysis against a control group
  93. Long-term Intrathecal Drug Administration for Chronic Nonmalignant Pain
  94. Type of Interventional Pain Procedure, Body Weight, and Presence of Spinal Pathology are Determinants of the Level of Radiation Exposure for Fluoroscopically Guided Pain Procedures
  95. Exposure from fluoroscopy in theatre
  96. Influence of a latent period in QALY anaylsis: Pilot study of intrathecal drug delivery systems for chronic non-malignant pain
  97. A systematic literature review of psychological characteristics as determinants of outcome for spinal cord stimulation therapy
  98. Cancer Pain: Part 2: Physical, Interventional and Complimentary Therapies; Management in the Community; Acute, Treatment-Related and Complex Cancer Pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine ...
  99. Cancer Pain: Part 1: Pathophysiology; Oncological, Pharmacological, and Psychological Treatments: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners
  100. Intrathecal inflammatory masses: is the yearly opioid dose increase an early indicator?